|
|
||||||||
Clinical Chemistry, Vol 39, 1382-1389, Copyright © 1993 by American Association for Clinical Chemistry
WC Taddei-Peters, BT Butman, GR Jones, TM Venetta, PF Macomber and JH Ransom
Organon Teknika/Biotechnology Research Institute, Rockville, MD 20850.
A quantitative sandwich ELISA for lipoprotein(a) [Lp(a)], utilizing a monoclonal capture antibody that recognizes human and rhesus monkey apolipoprotein(a) [apo(a)] isoforms in combination with a polyclonal anti-apolipoprotein B-peroxidase conjugate was developed. This assay generates a linear calibration curve from 31.2 to 1000 mg/L, is highly reproducible (intra- and interassay CV of < 5% and < or = 12%, respectively), and shows no interference from plasminogen (1 g/L), low- density lipoprotein (6.00 g/L), triglycerides (27.00 g/L from chylomicrons and 10.00 g/L from very-low-density lipoprotein), hemoglobin (5 g/L), or bilirubin (30 mg/L). This assay format quantifies the concentration of Lp(a) on an equal molar basis regardless of apo(a) isoform. In contrast, a commercially available ELISA [Macra Lp(a)] method with a monoclonal anti-apo(a) capture antibody and a polyclonal anti-apo(a) conjugate was found to underestimate the Lp(a) concentrations of individuals with lower-M(r) apo(a) isoforms--whether quantifying the Lp(a) in plasma or the purified lipoprotein. This demonstrates the importance of assay format selection in quantifying Lp(a).
The following articles in journals at HighWire Press have cited this article:
![]() |
S. R Teixeira, S. M Potter, R. Weigel, S. Hannum, J. W Erdman Jr, and C. M Hasler Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1077 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Seman, C. DeLuca, J. L. Jenner, L. A. Cupples, J. R. McNamara, P. W.F. Wilson, W. P. Castelli, J. M. Ordovas, and E. J. Schaefer Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study Clin. Chem., July 1, 1999; 45(7): 1039 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Rainwater, C. A. McMahan, G. T. Malcom, W. D. Scheer, P. S. Roheim, H. C. McGill Jr, and J. P. Strong Lipid and Apolipoprotein Predictors of Atherosclerosis in Youth : Apolipoprotein Concentrations Do Not Materially Improve Prediction of Arterial Lesions in PDAY Subjects Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 753 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Rainwater and S. M. Haffner Insulin and 2-Hour Glucose Levels Are Inversely Related to Lp(a) Concentrations Controlled for LPA Genotype Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1335 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramharack, D. Barkalow, and M. A. Spahr Dominant Negative Effect of TGF-ß1 and TNF-{alpha} on Basal and IL-6–Induced Lipoprotein(a) and Apolipoprotein(a) mRNA Expression in Primary Monkey Hepatocyte Cultures Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 984 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ryan, L. L. Emig, G. W. Hicks, R. Ramharack, M. A. Spahr, J. S. Kreick, D. W. Brammer, A. J. Chien, and J. A. Keiser Localization of Lipoprotein(a) in a Monkey Model of Rapid Neointimal Growth Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 181 - 187. [Abstract] [Full Text] |
||||
![]() |
J. L. Hoover-Plow, N. Boonmark, P. Skocir, R. Lawn, and E. F. Plow A Quantitative Immunoassay for the Lysine-Binding Function of Lipoprotein(a) : Application to Recombinant Apo(a) and Lipoprotein(a) in Plasma Arterioscler. Thromb. Vasc. Biol., May 1, 1996; 16(5): 656 - 664. [Abstract] [Full Text] |
||||
![]() |
R. Carmena, S. Lussier-Cacan, M. Roy, A. Minnich, A. Lingenhel, F. Kronenberg, and J. Davignon Lp(a) Levels and Atherosclerotic Vascular Disease in a Sample of Patients With Familial Hypercholesterolemia Sharing the Same Gene Defect Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 129 - 136. [Abstract] [Full Text] |
||||
![]() |
G. Jurgens, W. C. Taddei-Peters, P. Koltringer, W. Petek, Q. Chen, J. Greilberger, P. F. Macomber, B. T. Butman, A. G. Stead, and J. H. Ransom Lipoprotein(a) Serum Concentration and Apolipoprotein(a) Phenotype Correlate With Severity and Presence of Ischemic Cerebrovascular Disease Stroke, October 1, 1995; 26(10): 1841 - 1848. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |